The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-11.2% to $145.00
Predicted High$164.50in 2 weeks
Predicted Low$145.00at 6 months
Max Drawdown (predicted)-11.2%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 4, 2026 1:15 am
Bear
APH trends lower to
$145.00
(-11.2% from $163.34)
by Feb 2027.
ride-then-fade
ThesisAPH trades meaningfully above composite fair value with a negative value lens but strong quality; in a mild risk-on tape with no catalyst, momentum keeps it elevated near-term before valuation gravity pulls it toward the mid-140s over 6 months.
Invalidated ifA break above $175 on volume or below $145 would falsify the slow-fade path; a regime flip to risk-off would accelerate the decline.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $163.34 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 4, 2026
—
$163.34at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 18, 2026
$147.16–$179.52typical range · internal point $164.50
—
±9.9%
6/10
Risk-on tape and momentum carry price sideways-up
What actually happened:
closed $170.87
on Aug 17, 2026 = +4.6% vs the call
(predicted +0.7%)
· direction HIT
(called flat, was flat)
· off by 3.9 pp
· accuracy 9/10
· typical range ±9.9%:
inside the band
· S&P +0.6%
over the same window — beat it
1 month
Sep 4, 2026
$139.89–$186.79typical range · internal point $162.00
—
±14.4%
5/10
No catalyst; drift as high beta cools
2 months
Oct 4, 2026
$158.00
—
-3.3%
5/10
Valuation gravity begins pulling toward fair value
3 months
Nov 4, 2026
$154.00
—
-5.7%
4/10
Possible Q3 print tests premium multiple
4 months
Dec 4, 2026
$150.00
—
-8.2%
4/10
Year-end de-risking trims extended quality names
5 months
Jan 4, 2027
$147.00
—
-10.0%
3/10
January rebalance pressures overvalued winners
6 months
Feb 4, 2027
$145.00
—
-11.2%
3/10
Convergence toward composite fair value zone
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$158.95
(-2.7%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.